Concepedia
Statistics
Publications
21
Citations
1.3K
H-Index
17
Active since
2001
Affiliations
Research Triangle Park Foundation(Current)
GlaxoSmithKline (United Kingdom)
GlaxoSmithKline (United States)
Eli Lilly (United States)
Age UK
Matthew E. Barton is an author at Research Triangle Park Foundation specializing in pharmacology, medicine, and neuropharmacology.
Publications per year
2001–2019
Pharmacological characterization of the 6 Hz psychomotor seizure model of partial epilepsy
Matthew E. Barton, Brian D. Klein, Harold H. Wolf et al. · Epilepsy Research · 2001 · 618 citations
Medicine, Neuroscience, Pharmacology +7
Comparison of the effect of glutamate receptor modulators in the 6 Hz and maximal electroshock seizure models
Matthew E. Barton, Steven Peters, Harlan E. Shannon · Epilepsy Research · 2003 · 111 citations
Life Sciences, Neuroscience, Pharmacology +13
The antihyperalgesic effects of the T-type calcium channel blockers ethosuximide, trimethadione, and mibefradil
Matthew E. Barton, Elizabeth L. Eberle, Harlan E. Shannon · European Journal of Pharmacology · 2005 · 61 citations
Medicine, Pharmacology, Pharmacotherapy +7
Constitutive deletion of the serotonin-7 (5-HT7) receptor decreases electrical and chemical seizure thresholds
Jeffrey M. Witkin, Melvyn Baez, Jianliang Yu et al. · Epilepsy Research · 2007 · 48 citations
Modulation of LPS-induced pulmonary neutrophil infiltration and cytokine production by the selective PPARβ/δ ligand GW0742
Zdenka Hašková, Bao Hoang, Guo-Lun Luo et al. · Inflammation Research · 2008 · 45 citations
Life Sciences, Immunology, Pharmacology +16
1–5 of 21